title: Cholinergic modulation of trace conditioning trained in serial compound: A developmental analysis.
abstract: In four experiments the effects of serial compound conditioning on responding to a trace-conditioned CS were evaluated using a fear conditioning paradigm. The subjects were 18- and 25-day-old Sprague-Dawley rats, previously shown to exhibit little or no trace fear conditioning. Here, animals as young as 18 days of age were shown to be capable of trace conditioning between a visual CS1 and a shock US, provided the trace interval was filled with a non-target CS2 during serial conditioning trials (CS1-->CS2-->US). To explore cholinergic mechanisms involved in trace and serial conditioning, additional experiments assessed conditioned responding following pre-training administration of the muscarinic receptor antagonist scopolamine. Scopolamine produced a dose-dependent reduction in responding to the trace CS1, regardless of whether subjects were trained with standard trace (CS1-->trace interval-->US) or serial (CS1-->CS2-->US) trials. Responding to CS2 was unaffected by scopolamine. These data suggest that central cholinergic systems are functional in the young animals, but are not normally sufficiently activated by standard trace conditioning procedures. The results suggest that serial compound conditioning can promote trace conditioning in young rats, as it does in adults, perhaps by enhancing cholinergic activity during training. Implications for the late ontogenetic emergence of trace conditioning as it relates to maturation of neural pathways and their role in the potentiating effects of a gap filler are discussed.
authors.affiliation: Department of Psychology, College of William and Mary, PO Box 8795, Williamsburg, VA 23187-8795, USA. pshunt@wm.edu
authors.forename: Pamela S
authors.initials: PS
authors.lastname: Hunt
authors.forename: Robert C
authors.initials: RC
authors.lastname: Barnet
authors.forename: Meghan E
authors.initials: ME
authors.lastname: Shea
authors.forename: Eric M
authors.initials: EM
authors.lastname: Baker
mesh_terms: D000367:Age Factors; D000818:Animals; D001245:Association Learning / Q000187:drug effects / Q000502:physiology; D001362:Avoidance Learning / Q000187:drug effects / Q000502:physiology; D001921:Brain / Q000254:growth & development / Q000502:physiology*; D002799:Cholinergic Fibers / Q000187:drug effects / Q000502:physiology*; D003214:Conditioning, Classical / Q000187:drug effects / Q000502:physiology*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005239:Fear / Q000187:drug effects / Q000502:physiology*; D018727:Muscarinic Antagonists / Q000008:administration & dosage; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D012601:Scopolamine / Q000008:administration & dosage; D012691:Serial Learning / Q000187:drug effects / Q000502:physiology*
chemical_list: D018727:Muscarinic Antagonists; D012601:Scopolamine